Boston Scientific (BSX) Q3 2017 Results - Earnings Call Transcript

10/26/17

Thank you, Stacy. Good morning, everyone, and thanks for joining us. With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer, and Dan Brennan, Executive Vice President and Chief Financial Officer. We issued a press release earlier this morning announcing our Q3 2017 results, which included reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release as well as reconciliations of the non-GAAP measures used in today's call to the Investor Relations section of our website under the heading Investors/Filings/Quarterly Results and non-GAAP reconciliations.

The duration of this morning's call will be approximately one hour. Mike will provide strategic and revenue highlights for Q3 2017; Dan will review the financials for the quarter, and then Q4 2017 and full year 2017 guidance; and then, we'll take your questions. During today's Q&A session, Mike and Dan will be joined by our Chief Medical Officers, Dr. Ian Meredith, and Dr. Ken Stein.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.